Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
Launched by JEAN DUBUISSON · Mar 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a new minimally invasive surgical technique called vNOTES (transvaginal natural orifice transluminal endoscopic surgery) affects women's sexual quality of life after having surgery for benign adnexal conditions, like cysts or masses on the ovaries. Researchers want to see if vNOTES is just as good as the traditional method, known as conventional abdominal laparoscopy (CAL), in terms of safety and effectiveness, specifically focusing on how it impacts women's sexual health after surgery.
Women between the ages of 18 and 70 who have had sexual intercourse within the last month and can provide consent may be eligible to participate. Those with certain medical histories, like previous pelvic surgeries, active infections, or suspected cancers, will not be included. If you join the study, you can expect to undergo either the vNOTES or CAL approach for your surgery, and the team will closely monitor your recovery and sexual function afterward. This trial aims to provide valuable information for doctors and patients about the best surgical options for these conditions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged from 18 to 70 years
- • Discernment capacity with oral and written consent signed
- • Heterosexual intercourse (with vaginal penetration) within four weeks prior to inclusion in the study
- Exclusion Criteria:
- • History of rectal surgery.
- • Suspected rectovaginal/retrocervical endometriosis.
- • History of brachytherapy or pelvic radiation.
- • Suspected malignancy.
- • History of severe pelvic inflammatory disease.
- • Active lower genital tract infection.
- • Pregnancy.
- • Women who do not speak fluent French or English.
- • Patients under tutelage (with or without capacity of judgement).
About Jean Dubuisson
Jean Dubuisson is a distinguished clinical trial sponsor known for its commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, the organization collaborates with leading research institutions and healthcare professionals to facilitate the development of groundbreaking treatments. Through rigorous trial design and a dedication to ethical standards, Jean Dubuisson strives to contribute valuable insights to the medical community while ensuring the safety and well-being of participants. Their expertise spans various therapeutic areas, making them a trusted partner in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Trial Officials
Jean Dubuisson
Principal Investigator
University Hospital, Geneva
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials